18-11-2022 | Dapagliflozin | News
People who have heart failure with preserved ejection fraction benefit from dapagliflozin irrespective of whether they have normal or impaired glucose metabolism, shows further analysis of DELIVER.
08-11-2022 | SGLT2 inhibitors | News
A meta-analysis published in The Lancet supports the use of SGLT2 inhibitors in people with chronic kidney disease, irrespective of whether they have type 2 diabetes.
21-10-2022 | Cardiovascular disorders | News
The strength of the association between diabetes and the risk for cardiovascular events has lessened over recent years, report researchers.
10-03-2023 | Primary care | News
08-02-2023 | Heart failure | News
20-12-2022 | Dapagliflozin | News
06-12-2022 | Empagliflozin | News
02-12-2022 | Nephropathy | News
01-12-2022 | Semaglutide | News
21-11-2022 | Cancer | News
07-11-2022 | Lipid-lowering medications | News
Get the latest developments in diabetes delivered straight to your inbox